Literature DB >> 28840565

Interplay between hepatitis C virus and ARF4.

Na Zhang1, Youyang Ke2, Leiliang Zhang3.   

Abstract

In summary, we show here that HCV infection is associated with an upregulation of ARF4, which promotes HCV replication. Upon HCV infection, CREB3 was redistributed to nucleus and activated ARF4 transcription. Our studies demonstrate a host factor ARF4 upregulated in HCV replication, which may provide new therapeutic targets for antiviral therapy.

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28840565      PMCID： PMC6598887          DOI： 10.1007/s12250-017-4000-0

Source DB:  PubMed          Journal:  Virol Sin        ISSN： 1995-820X            Impact factor:   4.327


  12 in total

1.  Regulation of ADP-ribosylation factor 4 expression by small leucine zipper protein and involvement in breast cancer cell migration.

Authors:  Soon Young Jang; Sung-Wuk Jang; Jesang Ko
Journal:  Cancer Lett       Date:  2011-09-29       Impact factor: 8.679

2.  ARF1 activation dissociates ADRP from lipid droplets to promote HCV assembly.

Authors:  Na Zhang; Peiqi Yin; Liya Zhou; Hongyan Li; Leiliang Zhang
Journal:  Biochem Biophys Res Commun       Date:  2016-05-06       Impact factor: 3.575

3.  Hepatitis C virus core protein-induced loss of LZIP function correlates with cellular transformation.

Authors:  D Y Jin; H L Wang; Y Zhou; A C Chun; K V Kibler; Y D Hou; H Kung; K T Jeang
Journal:  EMBO J       Date:  2000-02-15       Impact factor: 11.598

4.  A functional genomic screen identifies cellular cofactors of hepatitis C virus replication.

Authors:  Andrew W Tai; Yair Benita; Lee F Peng; Sun-Suk Kim; Naoya Sakamoto; Ramnik J Xavier; Raymond T Chung
Journal:  Cell Host Microbe       Date:  2009-03-19       Impact factor: 21.023

5.  Luman, the cellular counterpart of herpes simplex virus VP16, is processed by regulated intramembrane proteolysis.

Authors:  Camilo Raggo; Noreen Rapin; Julie Stirling; Philipe Gobeil; Erin Smith-Windsor; Peter O'Hare; Vikram Misra
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

Review 6.  Host restriction factors for hepatitis C virus.

Authors:  Li-Ya Zhou; Lei-Liang Zhang
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

7.  Identification of class II ADP-ribosylation factors as cellular factors required for hepatitis C virus replication.

Authors:  Rayan Farhat; Karin Séron; Juliette Ferlin; Lucie Fénéant; Sandrine Belouzard; Lucie Goueslain; Catherine L Jackson; Jean Dubuisson; Yves Rouillé
Journal:  Cell Microbiol       Date:  2016-02-25       Impact factor: 3.715

8.  A CREB3-ARF4 signalling pathway mediates the response to Golgi stress and susceptibility to pathogens.

Authors:  Jan H Reiling; Andrew J Olive; Sumana Sanyal; Jan E Carette; Thijn R Brummelkamp; Hidde L Ploegh; Michael N Starnbach; David M Sabatini
Journal:  Nat Cell Biol       Date:  2013-11-03       Impact factor: 28.824

9.  ARF1 and GBF1 generate a PI4P-enriched environment supportive of hepatitis C virus replication.

Authors:  Leiliang Zhang; Zhi Hong; Wenyu Lin; Run-Xuan Shao; Kaku Goto; Victor W Hsu; Raymond T Chung
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

10.  Hepatitis C virus NS5A hijacks ARFGAP1 to maintain a phosphatidylinositol 4-phosphate-enriched microenvironment.

Authors:  Hongyan Li; Xiaojie Yang; Guangbo Yang; Zhi Hong; Liya Zhou; Peiqi Yin; Yan Xiao; Lingyi Chen; Raymond T Chung; Leiliang Zhang
Journal:  J Virol       Date:  2014-03-12       Impact factor: 5.103
View more
  2 in total

1.  COVID-19 Salivary Protein Profile: Unravelling Molecular Aspects of SARS-CoV-2 Infection.

Authors:  Eduardo Esteves; Vera M Mendes; Bruno Manadas; Rafaela Lopes; Liliana Bernardino; Maria José Correia; Marlene Barros; Ana Cristina Esteves; Nuno Rosa
Journal:  J Clin Med       Date:  2022-09-22       Impact factor: 4.964

2.  Toxoplasma gondii SAG1 targeting host cell S100A6 for parasite invasion and host immunity.

Authors:  Li-Juan Zhou; Jiao Peng; Min Chen; Li-Jie Yao; Wei Hao Zou; Cynthia Y He; Hong-Juan Peng
Journal:  iScience       Date:  2021-11-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.